BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Emerging Biotech

India’s Biotech Boom: Supriya Kashikar on Startups, Innovation, and the Road to 2030

India’s biotechnology sector is on a trajectory to reach $300 billion by 2030, fueled by a dynamic startup ecosystem, robust government initiatives l...

December 17, 2024 | Interview

Brazilian Biotech Nintx Secures $10 Million Series A Funding to Advance Multifactorial Disease Therapies

Startup funding includes a Series A round led by venture capital firms Pitanga, Ecoa Capital and MOV Investimentos, along with a grant from FINEP ...

December 16, 2024 | News

Hong Kong’s Viva Biotech Expands Global Footprint with Strategic Boston Branch Launch

Viva Biotech Holdings Group ("Viva Biotech") announced the official establishment of its new branch in Boston, USA. As a global leader in drug re...

December 12, 2024 | News

Duke Street Bio Initiates Phase I Trial of Highly Selective PARP1 Inhibitor DSB2455 for Solid Tumours

Duke Street Bio Ltd, a precision medicine biotech developing next-generation small molecule cancer therapies, is pleased to announce that the first patient...

December 12, 2024 | News

Skyhawk Therapeutics Gains Australian Approval to Extend SKY-0515 Huntington’s Disease Trial to 12 Weeks

Australian Human Research Ethics Committees approves SKY-0515 treatment for up to 12 weeks in the company's ongoing Phase 1 trial in patients with Hun...

December 10, 2024 | News

Nona Biosciences Partners with Kodiak Sciences to Accelerate Multi-Target Antibody Therapies for Ophthalmic Diseases

Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), ranging from target validation and antibody disc...

December 10, 2024 | News

Qi Biodesign Secures $75M in Series A Funding to Propel Next-Gen Genome Editing Innovations

Qi Biodesign, a biotechnology company pioneering next-generation genome editing technologies, announced the completion of its Series A funding round. The c...

December 09, 2024 | News

Cambrex Partners with Eli Lilly to Accelerate Biotech Innovation

Cambrex, a leading global contract development and manufacturing organization (CDMO), announced that it has signed an agreement with Eli Lilly and Company ...

December 06, 2024 | News

Duality Biologics and GSK Forge $1 Billion Partnership for Next-Generation ADC Candidate

Duality Biologics ("DualityBio"), a clinical-stage biotech company focusing on the discovery and development of next-generation antibody-drug conjugate (AD...

December 04, 2024 | News

Serina Therapeutics Secures $10 Million Equity Financing from JuvVentures to Advance Parkinson's Therapy

Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company, announced a $10 million equity fi...

December 03, 2024 | News

Vaxxas Expands Global Patent Portfolio to 42, Securing Exclusive Rights to HD-MAP Vaccination Technology

-Vaxxas, a clinical-stage biotechnology company, has expanded its global intellectual property portfolio to 42 patents, supporting its exclusive claim to m...

November 25, 2024 | News

Converge Bio Secures $5.5M Seed Funding to Transform Drug Discovery with Generative AI

Converge Bio, a generative AI platform for accelerated drug discovery and development, announced it has raised $5.5 million in seed funding, ...

November 21, 2024 | News

Singleron Biotechnologies Partners with TOMY Digital Biology to Expand Single Cell Analysis Solutions in Japan

Singleron Biotechnologies, a leader in single cell analysis solutions, has announced a new distributor partnership with TOMY Digital Biology Co., Ltd. Unde...

November 20, 2024 | News

Huahui Health's Libevitug Receives FDA Breakthrough Therapy Designation for Chronic Hepatitis Delta

Huahui Health, a clinical-stage biotechnology company focused on discovering and developing novel therapies in the areas of viral hepatitis, hepatology, an...

November 19, 2024 | News

Stay Connected